Week 364 Review - Virtually flat week with very little happening

An almost flat week. OPTI:Optibiotix put a slight downer on it, dropping 0.5p, and a few things rallied a little so the widening of deficit between cost and value was reduced to £560, making the gap £78,853 and total portfolio value £104,574.

No big losers this week.

JLP:Jubilee Metals went up 5% of my purchase price which isn't that much in current terms, but at least it's going in the right direction.

CAML:Central Asia Metals won Share of the Week for the 2nd week in a row, so is hopefully on a roll back to fair value. They went up 6% this week and are now 9% up and making £206 potential profit.

Stays just above the injection line

Gradually pulling the trend line flatter, but it won't get flat till we claw back another £50K of losses. More likely that it will take a few more months and by then we'll only need to have clawed back £25K of losses to make it flat.

Here's the ISA and shares portfolio after week 52 of year 7.

			Weekly Change
Cash	£100		+£0
Portfolio cost	£82,912.77		+£0
Portfolio sell value (bid price-commission)	£45,806.40	(-44.8%)	-£452.87
Potential profits	£1,244.55		+£27.00
Yr 7 Dividends	£10,425.77		+£0
Yr 7 Profit from sales	£3,970.12		+£0
Yr 7 projected avg monthly profit	£1,196.22	(32.4%)	-£23.46
Total Dividends	£11,768.92		+£0
Total Profit from sales	£28,094.06		+£0
Average monthly cash profit	£470.72	(12.7%)	-£1.29
(Sold stocks profit + Dividends - Fees / Months)
Compound performance	89%		+0%

The last week of year 7 and a relatively small dip of £452. JLP:Jubilee Metals is still the only share in profit, with nothing else remotely close to breaking even except for the PBX:Probiotix dividend shares which haven't changed price since they floated. The annual profit of 32.4% is nearly all down to the PBX dividend and the way I accounted for it. However, even without that dividend I managed bang on 10%, largely due to selling off most of my JLP:Jubilee Metals holding for between 250 and 300% profit. Long term performance is healthy at 12.7% but would be 9.5% without the dividend. I'd be pleased with that, at least until DDDD:4D Pharma go bust, in which case it would drop to about 6% so I need the divi to mitigate that.

Just above the injection line

Comfortably above the trend line.

The SIPP looks like this after week 348 overall and week 36 of year 7.

			Weekly Change
Cash	£103.73		+£0
Portfolio cost	£98,389.93		+£0
Portfolio sell value (bid price - commission)	£57,793.01	(-41.3%)	-£114.76
Potential profits	£236.72		+£150.64
Yr 7 Dividends	£10,727.13		+£0
Yr 7 Interest	£0.01		+£0
Yr 7 Profit from sales	£275.31		+£0
Yr 7 projected avg monthly profit	£1,309.44	(28.1%)	-£37.41
Total Dividends	£13,931.52		+£0
Total Interest	£0.21		+£0
Total Profit from sales	£23,999.94		+£0
Average monthly cash profit	£460.55	(9.9%)	-£1.32
(Sold stocks profit + Dividends - Fees / Months)
Compound performance	66%		+0%

Potential profits up by £140 thanks to CAML:Central Asia Metals putting on 6% just after I doubled my holding. PLUS:Plus500 also went up 1% to contribute. Lots of small increases elsewhere helped mitigate the drop in OPTI:Optibiotix so value only dropped £114.

Similar to ISA

Only need £20K to flatten the trend line

The trading account looks like this after week 314 overall and week 2 of year 7.

			Weekly Change
Cash	£43.18		+£0
Portfolio cost	£1,877.84		+£0
Portfolio sell value (bid price - commission)	£727.95	(-61.2%)	+£6.95
Potential profits	£0.00		+£0
Year 7 Dividends	£0.00		+£0
Year 7 Profit	£0.00		+£0
Yr 7 projected avg monthly profit	£0.00	(0.0%)	+£0
Dividends	£60.10		+£0
Profit from sales	£226.60		+£0
Average monthly cash profit	£3.96	(2.5%)	-£0.01
(Sold stocks profit + Dividends - Fees / Months)

Small increase in JLP:Jubilee Metals helped lift the gloom on this desperate account, but only by £6.

Best you can say is the drop has stalled.

75% of the account is suspended and only one share active. Hard to see how it could be much worse.

I was hoping for momentum to build with OPTI:Optibiotix as last time we had this sort of optimism we shot up. Looks like a period of consolidation waiting for the next news. Frustrating when you don't know if it's coming in months or days.